Jason D. Smith Attorney-In-Fact Net Worth & Insider Trades

Jason D. Smith Attorney-In-Fact - General Counsel, Urogen Pharma Ltd

As of September 2, 2022

What is Jason D. Smith Attorney-In-Fact's Net Worth?

The current estimated net worth of Urogen Pharma Ltd's General Counsel, Jason D. Smith Attorney-In-Fact, is estimated to be about $93.76K . Jason D. Smith Attorney-In-Fact owns about 12,176 units of Urogen Pharma Ltd common stock. In the last year at Urogen Pharma Ltd, Jason D. Smith Attorney-In-Fact has sold an estimated value of $29.14K worth.

What is Jason D. Smith Attorney-In-Fact's Past Insider Trading?

Jason D. Smith Attorney-In-Fact's largest purchase order was 2,500 units , worth over $39.27K on May 18, 2021. Jason D. Smith Attorney-In-Fact's largest sale order was 3,606 units , worth over $26K on September 2, 2022. In total, Jason D. Smith Attorney-In-Fact has made about 4 transactions over a year of their time at Urogen Pharma Ltd. Jason D. Smith Attorney-In-Fact usually trades in February, with the busiest year in 2021 and 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Jason D. Smith Attorney-In-Fact's Salary in 2020?

As General Counsel of Urogen Pharma Ltd, Jason D. Smith Attorney-In-Fact has a total base salary of $126,930 . Jason D. Smith Attorney-In-Fact received compensation valued at about $1,615,274 in 2020 after becoming General Counsel. The vast majority of their compensation came in the form of a bonus of $100,000 , stock awards of $491,500 , option awards of $785,242 , other earnings, plans or compensations of $92,083 , and other compensation of $19,518 .

What is Jason D. Smith Attorney-In-Fact's' Mailing Address?

  • Mailing address is C/o Urogen Pharma Ltd. 400 Alexander Park Drive Princeton NJ 08540 NJ

Urogen Pharma Ltd Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Elizabeth Barrett 2020 $636,987 $0 $441,150 $876,164 $468,650 $43,716 $2,466,667
Elizabeth Barrett 2019 $694,697 $300,000 $15,082,782 $8,979,216 $840,000 $4,128 $25,900,823
Molly Henderson 2020 $94,269 $100,000 $294,900 $787,994 $69,875 $15,192 $1,362,230
Peter P. Pfreundschuh 2020 $324,329 $0 $176,460 $292,055 $218,800 $152,313 $1,163,956
Peter P. Pfreundschuh 2019 $435,625 $0 $212,500 $436,108 $261,375 $1,183 $1,346,791
Peter P. Pfreundschuh 2018 $156,424 $0 $527,875 $1,704,505 $96,800 $197 $2,485,800
Stephen L. Mullennix 2020 $139,311 $0 $88,230 $292,055 $140,200 $246,581 $906,376
Stephen L. Mullennix 2019 $435,625 $0 $212,500 $436,108 $261,375 $904 $1,346,512
Stephen L. Mullennix 2018 $359,754 $70,000 $1,102,893 $2,552,946 $223,400 $575 $4,309,568
Mark Schoenberg 2020 $185,026 $0 $176,460 $292,054 $293150 $1,767 $948,458
Mark Schoenberg 2019 $205,000 $0 $106,250 $218,054 $270,000 $1,604 $800,908
Mark Schoenberg 2018 $200,000 $0 $0 $0 $100,000 $0 $300,000
Jason Smith 2020 $126,930 $100,000 $491,500 $785,242 $92,083 $19,518 $1,615,274
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1668243/000156459021021330/urgn-def14a_20210607.htm

What are Urogen Pharma Ltd's Past Insider Trades?

Urogen Pharma Ltd's most recent insider trade came on September 2, 2022 by Jason D. Smith Attorney-In-Fact who sold 3,606 units worth $26K . In the last 5 years, insiders at Urogen Pharma Ltd have sold an estimated value of $9.75M and bought an estimated value of $2.41M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Mark Schoenberg, Chief Medical Officer,  Elizabeth Barrett, Chief Executive Officer,  and Peter Pfreundschuh, Chief Financial Officer .

UroGen Pharma Ltd. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1